Skip to main content

Fumonisin B1

BML-SL220

16 citations

  • BML-SL220-0001   —   1 mg
    $117.00
  • BML-SL220-0005   —   5 mg
    $524.00
  • Highly pure sphingosine n-acyl transferase inhibitor
  • Used in a variety of reseach fields including cancer, food science, and neuroscience

Fumonisin B1 (FB1) is a mycotoxin produced by Fusarium moniliforme. FB1 inhibits sphingosine N-acyl-transferase (ceramide synthase)(IC50 = 0.1µM) and de novo sphingolipid biosynthesis (IC50=0.7µM for sphingomyelin labeling by [3H]sphinganine, cultured cerebellar neurons). FB1 inhibits growth of axons in cultured hippocampal neurons by blocking glycosphingolipid synthesis. In CV-1 cells, FB1 induces DNA damage (5µM) and apoptosis (25µM). FB1 also activates Akt (PKB), which leads to increased survival, inhibition of GSK-3β activity, and post-translational stabilization of cyclin D1.

Shipping: Available products typically ship within 24/48h, via priority shipping.

Do you need support? Contact Customer Service or Technical Support.

Online Account
Access or Create Your Account


Regulatory Status

RUO – Research Use Only